PHIO PHARMACEUTICALS CORP. Accounts Payable
PHIO PHARMACEUTICALS CORP. (PHIO) had Accounts Payable of $901.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $901.00K.
- 2026-03-31: Accounts Payable, Current $260.00K.
- 2025-12-31: Accounts Payable, Current $435.00K.
- 2025-09-30: Accounts Payable, Current $516.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $901.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $260.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $435.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $516.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $235.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $427.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $253.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $184.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $335.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $320.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $657.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $173.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $641.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $902.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $779.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $543.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $329.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $283.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $322.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $348.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $615.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $728.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $742.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $481.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $685.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $809.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $856.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $736.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $721.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $550.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $491.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $542.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $521.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $511.00K 10-K · filed 2019-03-27 |
| 2017-09-30 | $702.00K 10-Q/A · filed 2018-03-26 |
| 2017-06-30 | $741.00K 10-Q/A · filed 2018-03-26 |
| 2017-03-31 | $672.00K 10-Q/A · filed 2018-03-26 |
| 2016-12-31 | $917.00K 10-Q/A · filed 2018-03-26 |
| 2016-09-30 | $457.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $297.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $281.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.16M 10-K · filed 2017-03-30 |
| 2015-09-30 | $222.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $635.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $459.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $285.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $137.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $293.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $277.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $163.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $177.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $358.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $366.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $416.00K 10-K · filed 2014-03-28 |
| 2012-09-30 | $155.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $277.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $747.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $387.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |